Application Sponsors
ANDA 040560 | NOSTRUM LABS INC | |
Marketing Status
Prescription | 001 |
Prescription | 002 |
Prescription | 003 |
Application Products
001 | TABLET, EXTENDED RELEASE; ORAL | 600MG | 0 | THEOPHYLLINE | THEOPHYLLINE |
002 | TABLET, EXTENDED RELEASE;ORAL | 600MG | 0 | THEOPHYLLINE | THEOPHYLLINE |
003 | TABLET, EXTENDED RELEASE;ORAL | 400MG | 0 | THEOPHYLLINE | THEOPHYLLINE |
FDA Submissions
| ORIG | 1 | AP | 2006-04-21 | |
LABELING; Labeling | SUPPL | 6 | AP | 2015-11-20 | STANDARD |
Submissions Property Types
TE Codes
002 | Prescription | AB |
003 | Prescription | AB |
CDER Filings
NOSTRUM LABS INC
cder:Array
(
[0] => Array
(
[ApplNo] => 40560
[companyName] => NOSTRUM LABS INC
[docInserts] => ["",""]
[products] => [{"drugName":"THEOPHYLLINE","activeIngredients":"THEOPHYLLINE","strength":"600MG","dosageForm":"TABLET, EXTENDED RELEASE; ORAL","marketingStatus":"Prescription","te":"None","rld":"No","rs":"No"},{"drugName":"THEOPHYLLINE","activeIngredients":"THEOPHYLLINE","strength":"600MG","dosageForm":"TABLET, EXTENDED RELEASE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"Yes"},{"drugName":"THEOPHYLLINE","activeIngredients":"THEOPHYLLINE","strength":"400MG","dosageForm":"TABLET, EXTENDED RELEASE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"THEOPHYLLINE","submission":"THEOPHYLLINE","actionType":"600MG","submissionClassification":"TABLET, EXTENDED RELEASE; ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"},{"actionDate":"THEOPHYLLINE","submission":"THEOPHYLLINE","actionType":"600MG","submissionClassification":"TABLET, EXTENDED RELEASE;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"},{"actionDate":"THEOPHYLLINE","submission":"THEOPHYLLINE","actionType":"400MG","submissionClassification":"TABLET, EXTENDED RELEASE;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
[supplements] =>
[actionDate] => 1969-12-31
)
)